Product NDC: | 17312-023 |
Proprietary Name: | Ring Relief |
Non Proprietary Name: | ARNICA MONTANA - CALCIUM SULFIDE - HYPERICUM PERFORATUM - LYCOPODIUM CLAVATUM SPORE - MERCURIUS SOLUBILIS - SALICYLIC ACID - SILICON DIOXIDE - ALLYLTHIOUREA - |
Active Ingredient(s): | 6; 6; 13; 6; 12; 13; 6; 13 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 & nbsp; ARNICA MONTANA - CALCIUM SULFIDE - HYPERICUM PERFORATUM - LYCOPODIUM CLAVATUM SPORE - MERCURIUS SOLUBILIS - SALICYLIC ACID - SILICON DIOXIDE - ALLYLTHIOUREA - |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 17312-023 |
Labeler Name: | TRP Company |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED HOMEOPATHIC |
Start Marketing Date: | 20111201 |
Package NDC: | 17312-023-14 |
Package Description: | 1 BOTTLE in 1 PACKAGE (17312-023-14) > 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE |
NDC Code | 17312-023-14 |
Proprietary Name | Ring Relief |
Package Description | 1 BOTTLE in 1 PACKAGE (17312-023-14) > 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE |
Product NDC | 17312-023 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | ARNICA MONTANA - CALCIUM SULFIDE - HYPERICUM PERFORATUM - LYCOPODIUM CLAVATUM SPORE - MERCURIUS SOLUBILIS - SALICYLIC ACID - SILICON DIOXIDE - ALLYLTHIOUREA - |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20111201 |
Marketing Category Name | UNAPPROVED HOMEOPATHIC |
Labeler Name | TRP Company |
Substance Name | ALLYLTHIOUREA; ARNICA MONTANA; CALCIUM SULFIDE; HYPERICUM PERFORATUM; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; SALICYLIC ACID; SILICON DIOXIDE |
Strength Number | 6; 6; 13; 6; 12; 13; 6; 13 |
Strength Unit | [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 |
Pharmaceutical Classes |